# Osimertinib-Adherence-Predictor
Predictive analytics model leveraging a neural network to identify patients at risk of prematurely ending Osimertinib treatment for non-small cell lung cancer (NSCLC). Achieved an AUC of 0.93 on validation data through focused feature selection.
